Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

Last updated: September 14, 2021
Sponsor: Ocular Therapeutix, Inc.
Overall Status: Completed

Phase

3

Condition

Glaucoma

Vascular Diseases

Circulation Disorders

Treatment

N/A

Clinical Study ID

NCT02914509
OTX-16-002
  • Ages > 18
  • All Genders

Study Summary

The objective of the study is to evaluate evaluate the safety and IOP lowering efficacy of OTX-TP, a sustained release travoprost drug product, placed in the canaliculus of the eyelid in the treatment of subjects with open-angle glaucoma or ocular hypertension

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Documented diagnosis of ocular hypertension with an open angle of Schaffer Grade 3 orgreater or open-angle glaucoma without pseudoexfoliation or pigment dispersion orevidence of traumatic angle recession
  • IOP is currently controlled as assessed by the Investigator

Exclusion

Exclusion Criteria:

  • Punctum size smaller than 0.4 mm or greater than 0.9 mm in either eye as measuredusing a standard punctum gauge
  • A history of an inadequate response or no response to topical prostaglandin
  • Known or suspected allergy and/or hypersensitivity to travoprost or any prostaglandin,fluorescein, or to any component of the study products

Study Design

Total Participants: 565
Study Start date:
November 07, 2016
Estimated Completion Date:
March 30, 2019

Study Description

This was a prospective, multicenter, randomized, parallel-arm, double masked, placebo vehicle (PV) controlled study conducted to evaluate the safety and IOP-lowering efficacy of OTX-TP, a sustained release drug product placed in the canaliculus of the eyelid in subjects with open-angle glaucoma or ocular hypertension. A total of up to 550 subjects (1100 eyes) with a clinical diagnosis of open-angle glaucoma or ocular hypertension in both eyes received either OTX-TP or PV to evaluate the safety and efficacy of OTX-TP.

Connect with a study center

  • Artesia, California
    United States

    Site Not Available

  • Colorado Springs, Colorado
    United States

    Site Not Available

  • Lakeland, Florida
    United States

    Site Not Available

  • Morrow, Georgia
    United States

    Site Not Available

  • empty

    Shawnee, Kansas
    United States

    Site Not Available

  • Shawnee Mission, Kansas
    United States

    Site Not Available

  • Des Peres, Missouri
    United States

    Site Not Available

  • Fichte, Endl & Elmer Eyecare

    Amherst, New York 14228
    United States

    Site Not Available

  • Rochester, New York
    United States

    Site Not Available

  • Raleigh, North Carolina
    United States

    Site Not Available

  • Cincinnati, Ohio
    United States

    Site Not Available

  • Austin, Texas
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.